Skip to main content
. 2012 Nov 20;109(50):20467–20472. doi: 10.1073/pnas.1218535109

Fig. 3.

Fig. 3.

Ribosome-free L5 and L11 are not degraded by proteasomes upon ActD treatment. (A) A549 cells were treated with ActD for 5 h in the presence or absence of MG132. Nonribosomal fractions were immunoblotted with the indicated antibodies. (B) H1299 cells expressing YFP-L11 or YFP-S6 were transfected with HA-Ub for 24 h and then treated as indicated for 6 h, followed by staining with anti-HA antibody (red) and analysis by CLSM. (Scale bar, 5 μm.)